Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Positron Emission Tomography (PET) Imaging of the Enhanced Permeability and Retention (EPR) Effect With [89Zr]DFO-starPEG in Patients With Solid Tumors

NCT06894745 is registered in ClinicalTrials.gov with Robert Flavell, MD, PhD as lead sponsor.

NCT NCT06894745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06894745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Positron Emission Tomography (PET) Imaging of the Enhanced Permeability and Retention (EPR) Effect With [89Zr]DFO-starPEG in Patients With Solid Tumors
Lead sponsor
Robert Flavell, MD, PhD
Phase
Phase 1
Overall status
Recruiting
Start date
June 2, 2025
Completion date
December 31, 2027
Enrollment
13 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue lesion, solid carcinoma, solid tumor